NDC Package 81968-020-09 Symbravo

Meloxicam,Rizatriptan Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
81968-020-09
Package Description:
9 TABLET in 1 BOTTLE
Product Code:
Proprietary Name:
Symbravo
Non-Proprietary Name:
Meloxicam, Rizatriptan
Substance Name:
Meloxicam; Rizatriptan Benzoate
Usage Information:
SYMBRAVO is indicated for the acute treatment of migraine with or without aura in adults.Limitations of UseSYMBRAVO should only be used where a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with SYMBRAVO, the diagnosis of migraine should be reconsidered before SYMBRAVO is administered to treat any subsequent attacks.SYMBRAVO is not indicated for the preventive treatment of migraine attacks.SYMBRAVO is not indicated for the treatment of cluster headache.
11-Digit NDC Billing Format:
81968002009
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
9 EA
Product Type:
Human Prescription Drug
Labeler Name:
Axsome Therapeutics, Inc.
Dosage Form:
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Sample Package:
No
FDA Application Number:
NDA215431
Marketing Category:
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date:
05-19-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
81968-020-031 BOTTLE in 1 CARTON / 3 TABLET in 1 BOTTLE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 81968-020-09?

The NDC Packaged Code 81968-020-09 is assigned to a package of 9 tablet in 1 bottle of Symbravo, a human prescription drug labeled by Axsome Therapeutics, Inc.. The product's dosage form is tablet and is administered via oral form.

Is NDC 81968-020 included in the NDC Directory?

Yes, Symbravo with product code 81968-020 is active and included in the NDC Directory. The product was first marketed by Axsome Therapeutics, Inc. on May 19, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 81968-020-09?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 9.

What is the 11-digit format for NDC 81968-020-09?

The 11-digit format is 81968002009. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-281968-020-095-4-281968-0020-09